Aspen is expected to receive another $75 million, which will be held in escrow, upon satisfaction of certain conditions. Arixtra is approved for the treatment of deep vein thrombosis (DVT.V), which ...

As per the terms of the agreement, Aspen will acquire worldwide rights to Arixtra and Fraxiparine in all territories excluding China, India and Pakistan. However, Glaxo will continue to distribute and ...

PITTSBURGH, Sept. 10, 2014 /PRNewswire/ -- Mylan Inc. MYL, +0.23% today announced that its subsidiary Mylan Ireland Limited has entered into an agreement to acquire the U.S. commercialization, ...

The government approved a new type of blood thinner Monday that generated doctor excitement when studies suggested it cut the risk of blood clots after hip and knee surgery far more than standard ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Fondaparinux (Arixtra 2.5mg) is an anticoagulant ...

GlaxoSmithKline is upping the ante in its bid to win market share from Sanofi-Aventis’ number one clotbusting drug, Lovenox (enoxaparin), and yesterday unveiled data at the European Society of ...

SAN FRANCISCO (CBS.MW) -- Adolor Corp. said Monday after the bell that it has signed a two-year agreement with GlaxoSmithKline to co-promote Arixtra in the United States. Under the terms of the deal, ...

June 9, 2005 — The U.S. Food and Drug Administration (FDA) has approved a capsule formulation of paricalcitol for the prevention and treatment of secondary hyperparathyroidism in patients with stage ...

GlaxoSmithKline’s plans to get its anticoagulant drug Arixtra approved in a new indication have been set back somewhat by the US Food and Drug Administration’s request for more information.

Chicago, IL - Results of a new randomized trial show that extended prophylaxis up to four weeks with the factor Xa inhibitor fondaparinux (Arixtra ®, Sanofi-Synthelabo/Organon) reduced the risk of ...